Robert J. Bitterman, Chairman, President & CEO at Phio Pharmaceuticals Corp. (PHIO), bought 5,000 shares at $1.27 ($6K) on 2025-11-18, disclosed to the SEC on 2025-11-19.
Open-market purchase of $6k PHIO by Chairman, President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| PHIO | BUY | 2026-01-02 | $5K | — | Filing → |
| PHIO | BUY | 2025-12-29 | $5K | — | Filing → |
| PHIO | BUY | 2025-11-24 | $6K | — | Filing → |